Role of the gut microbiome in cardiovascular drug response: The potential for clinical application
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 42, Issue 2, Pages 165-176
Publisher
Wiley
Online
2021-11-26
DOI
10.1002/phar.2650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship Between the Gastrointestinal Side Effects of an Anti-Hypertensive Medication and Changes in the Serum Lipid Metabolome
- (2020) Yoomin Ahn et al. Nutrients
- Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects
- (2020) Risheng Zhao et al. GASTROENTEROLOGY
- Interaction between drugs and the gut microbiome
- (2020) Rinse K Weersma et al. GUT
- Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring
- (2020) Hong-Bao Li et al. HYPERTENSION
- Rosuvastatin alters the genetic composition of the human gut microbiome
- (2020) Martin Kummen et al. Scientific Reports
- Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
- (2020) Friederike Zimmermann et al. Journal of Clinical Medicine
- The gut microbes, Enterococcus and Escherichia-Shigella, affect the responses of heart valve replacement patients to the anticoagulant warfarin
- (2020) Lin Wang et al. PHARMACOLOGICAL RESEARCH
- In vitro fermentation and isolation of heparin-degrading bacteria from human gut microbiota
- (2020) Lin Pan et al. ANAEROBE
- Sustained Captopril‐Induced Reduction in Blood Pressure Is Associated With Alterations in Gut‐Brain Axis in the Spontaneously Hypertensive Rat
- (2019) Tao Yang et al. Journal of the American Heart Association
- Bringing microbiome-drug interaction research into the clinic
- (2019) Leah Guthrie et al. EBioMedicine
- Zhengganxifeng Decoction Affects Gut Microbiota and Reduces Blood Pressure via Renin–Angiotensin System
- (2019) Xiaoying Yu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Candesartan attenuates hypertension-associated pathophysiological alterations in the gut
- (2019) Dandan Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Gut Microbiota-Mediated Drug-Drug Interaction between Amoxicillin and Aspirin
- (2019) Juanhong Zhang et al. Scientific Reports
- Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects
- (2019) Iñaki Robles‐Vera et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension
- (2019) Francine Z. Marques et al. HYPERTENSION
- Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice
- (2018) Maimaiti Yisireyili et al. BRAIN BEHAVIOR AND IMMUNITY
- Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine
- (2018) Juanhong Zhang et al. DRUG DELIVERY
- Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme
- (2018) Kundan Kumar et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The influence of the intestinal microflora to the efficacy of Rosuvastatin
- (2018) Lijun Wang et al. Lipids in Health and Disease
- Current understanding of the human microbiome
- (2018) Jack A Gilbert et al. NATURE MEDICINE
- Gut microbiota associations with common diseases and prescription medications in a population-based cohort
- (2018) Matthew A. Jackson et al. Nature Communications
- Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats
- (2018) Tariq Jamal Khan et al. Scientific Reports
- Pharmacomicrobiomics: a novel route towards personalized medicine?
- (2018) Marwah Doestzada et al. Protein & Cell
- Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
- (2018) Yinhui Liu et al. Frontiers in Microbiology
- Extensive impact of non-antibiotic drugs on human gut bacteria
- (2018) Lisa Maier et al. NATURE
- Characterization of bacterial microbiota compositions along the intestinal tract in pigs and their interactions and functions
- (2018) Daniel Crespo-Piazuelo et al. Scientific Reports
- Gut microbiota functions: metabolism of nutrients and other food components
- (2017) Ian Rowland et al. EUROPEAN JOURNAL OF NUTRITION
- Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alpha
- (2017) James M. Davison et al. GENOME RESEARCH
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
- (2017) Nichole R. Klatt et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model
- (2017) S.-C. Song et al. Beneficial Microbes
- Statins: antimicrobial resistance breakers or makers?
- (2017) Humphrey H.T. Ko et al. PeerJ
- Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
- (2017) Jose A. Caparrós-Martín et al. Microbiome
- Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor β-Deficient Colon Cancer
- (2017) Scott G. Daniel et al. mSystems
- Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin
- (2016) In Sook Kim et al. BIOCHEMICAL PHARMACOLOGY
- High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE−/− mice
- (2016) Yee Kwan Chan et al. BMC MICROBIOLOGY
- Hypertension-Linked Pathophysiological Alterations in the GutNovelty and Significance
- (2016) Monica M. Santisteban et al. CIRCULATION RESEARCH
- The influence of non-steroidal anti-inflammatory drugs on the gut microbiome
- (2016) M.A.M. Rogers et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effects of orally administered antibiotics on the bioavailability of amlodipine
- (2016) Hye Hyun Yoo et al. JOURNAL OF HYPERTENSION
- Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms
- (2016) Hannah R. Wardill et al. MOLECULAR CANCER THERAPEUTICS
- Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
- (2016) Alexandra Zhernakova et al. SCIENCE
- Population-level analysis of gut microbiome variation
- (2016) Gwen Falony et al. SCIENCE
- Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases
- (2016) Piu Saha et al. PLoS One
- Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
- (2015) Caleb J. Kelly et al. Cell Host & Microbe
- The role of the gut microbiome in the healthy adult status
- (2015) Valeria D’Argenio et al. CLINICA CHIMICA ACTA
- Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults
- (2015) Ishak Mansi et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice
- (2014) Zidong Donna Fu et al. JOURNAL OF LIPID RESEARCH
- Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats
- (2014) Zuzana Matuskova et al. PLoS One
- Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease
- (2014) Hany H. Arab et al. PLoS One
- Oral administration of heparin or heparosan increases the Lactobacillus population in gut microbiota of rats
- (2013) Rongshuai Duan et al. CARBOHYDRATE POLYMERS
- Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
- (2013) H. J. Haiser et al. SCIENCE
- Warfarin Pharmacogenetics
- (2012) Julie A. Johnson CIRCULATION
- Statin use and the risk ofClostridium difficilein academic medical centres
- (2012) Christine Anne Motzkus-Feagans et al. GUT
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Severe Spruelike Enteropathy Associated With Olmesartan
- (2012) Alberto Rubio-Tapia et al. MAYO CLINIC PROCEEDINGS
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Pharmacogenomics
- (2011) Dan M. Roden et al. CIRCULATION
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Enterotypes of the human gut microbiome
- (2011) Manimozhiyan Arumugam et al. NATURE
- Genomics and Drug Response
- (2011) Liewei Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
- (2011) Rima Kaddurah-Daouk et al. PLoS One
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-Analysis
- (2010) Linda Björkhem-Bergman et al. PLoS One
- Epithelial crosstalk at the microbiota-mucosal interface
- (2010) J. M. Wells et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
- (2010) L. Dethlefsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbial Influences in Inflammatory Bowel Diseases
- (2008) R. Balfour Sartor GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now